Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines, Pediatr Blood Cancer, vol.42, pp.410-415, 2004. ,
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion, J Biol Chem, vol.283, pp.30549-30556, 2008. ,
Risedronate inhibits human osteosarcoma cell invasion, J Exp Clin Cancer Res, vol.28, p.105, 2009. ,
Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells, J Bone Joint Surg Br, vol.84, pp.706-711, 2002. ,
VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma, Surg Oncol, vol.20, pp.13-19, 2011. ,
, Annu Rev Med, vol.57, pp.1-18, 2006.
Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma, Cancer, vol.117, pp.4925-4938, 2011. ,
Expression of vascular endothelial growth factor correlates with the advance of clinical osteosarcoma, Int Orthop, vol.36, pp.2307-2313, 2012. ,
Cellretained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma, Eur J Cancer, vol.35, pp.1089-1093, 1999. ,
Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis, Clin Cancer Res, vol.6, pp.572-577, 2000. ,
Expression of VEGF and its receptors and angiogenesis in bone and soft tissue tumors, Anticancer Res, vol.26, pp.4307-4311, 2006. ,
Markers of angiogenesis and clinical features in patients with sarcoma, Cancer, vol.109, pp.813-819, 2007. ,
Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study, Int Orthop, vol.36, pp.2315-2321, 2012. ,
A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma, Tumour Biol, vol.34, pp.1895-1899, 2013. ,
Prognostic relevance of increased angiogenesis in osteosarcoma, Clin Cancer Res, vol.10, pp.8531-8537, 2004. ,
CCN1/CYR61: the very model of a modern matricellular protein, Cell Mol Life Sci, vol.68, pp.3149-3163, 2011. ,
Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells, J Biol Chem, vol.277, pp.46248-46255, 2002. ,
Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells, J Biol Chem, vol.279, pp.44166-44176, 2004. ,
CYR61 (CCN1) is essential for placental development and vascular integrity, Mol Cell Biol, vol.22, pp.8709-8720, 2002. ,
CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth, Proc Natl Acad Sci, vol.95, pp.6355-6360, 1998. ,
The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives, Endocr Relat Cancer, vol.10, pp.141-152, 2003. ,
Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer, Endocr Relat Cancer, vol.11, pp.781-791, 2004. ,
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells, Br J Cancer, vol.99, pp.1656-1667, 2008. ,
CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis, J Bone Miner Res, vol.26, pp.1533-1542, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00626140
Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice, J Bone Miner Res, vol.27, pp.58-67, 2012. ,
B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis, PLoS ONE, vol.8, p.70689, 2013. ,
Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis, Tumour Biol, vol.35, pp.845-848, 2014. ,
How matrix metalloproteinases regulate cell behavior, Annu Rev Cell Dev Biol, vol.17, pp.463-516, 2001. ,
CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis, Mod Pathol, vol.19, pp.738-745, 2006. ,
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways, Mol Cancer, vol.8, p.118, 2009. ,
SC-1, a sorafenib derivative, shows anti-tumor effects in osteogenic sarcoma cells, J Orthop Res, vol.31, pp.335-342, 2013. ,
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study, Ann Oncol, vol.23, pp.508-516, 2012. ,
Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors, Pediatr Blood Cancer, vol.60, pp.1447-1451, 2013. ,
Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing, J Biol Chem, vol.282, pp.26746-26753, 2007. ,
,
placental growth factor, and fibroblast growth factors-1 and -2 in the sera of patients with primary osteosarcomas, Bull Exp Biol Med, vol.148, pp.246-249, 2009. ,
Analysis report for osteosarcoma expression profile, Eur Rev Med Pharmacol Sci, vol.17, pp.2804-2809, 2013. ,
Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells, Cancer Sci, vol.105, pp.186-194, 2014. ,
The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin ?5?1, p38 MAPK, and matrix metalloproteinases, Sci Signal, vol.7, p.7, 2014. ,
An expression signature classifies chemotherapy-resistant pediatric osteosarcoma, Cancer Res, vol.65, pp.1748-1754, 2005. ,
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program, Pediatr Blood Cancer, vol.50, pp.581-587, 2008. ,
Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphav-beta3, J Biol Chem, vol.273, pp.3090-3096, 1998. ,
A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway, Oncogene, vol.24, pp.761-779, 2005. ,
A mechanism for modulation of cellular responses to VEGF: activation of the integrins, Mol Cell, vol.6, pp.851-860, 2000. ,
SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity, Invest Ophthalmol Vis Sci, vol.47, pp.1600-1605, 2006. ,
Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells, Mol Cell Biochem, vol.224, pp.81-89, 2001. ,
Prognostic significance of alpha V integrin and VEGF in osteosarcoma after chemotherapy, Onkologie, vol.31, pp.535-540, 2008. ,
Shear stress induced release of von Willebrand factor and thrombospondin-1 in HUVEC extracellular matrix enhances breast tumour cell adhesion, Clin Exp Metastasis, vol.22, pp.215-223, 2005. ,
Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors, Cancer Lett, vol.218, pp.1-14, 2005. ,
Secretome from mesenchymal stem cells induces angiogenesis via Cyr61, J Cell Physiol, vol.219, pp.563-571, 2009. ,
A Key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in tumor cells, Mol Cancer Res, vol.6, pp.1397-1409, 2008. ,
Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity noninvasive bioluminescence imaging, Stem Cells Dev, vol.17, pp.993-1003, 2008. ,
Analysis of progenitor cell-scaffold combinations by in vivo non-invasive photonic imaging, Biomaterials, vol.28, pp.2718-2728, 2007. ,